ID | 48895 |
フルテキストURL | |
著者 |
Nogami, Tomohiro
Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Shien, Tadahiko
Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
publons
researchmap
Nishiyama, Keiko
Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Mizoo, Taeko
Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Iwamto, Takayuki
Department of Breast and Endocrine Surgery, Okayama University Hospital
Ikeda, Hirokuni
Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Taira, Naruto
Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
publons
Doihara, Hiroyoshi
Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
researchmap
Miyoshi, Shinichiro
Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
publons
researchmap
|
抄録 | Background
Recently, evidence in support of the cancer stem cell (CSC) hypothesis has been accumulating. On the other hand, it has been reported that the expression of aldehyde dehydrogenase 1 (ALDH1) in primary breast cancer is a powerful predictor of a poor clinical outcome, and that breast cancer stem cells express ALDH1. According to the CSC hypothesis, development of metastases requires the dissemination of CSC that may remain dormant and be reactivated to cause tumor recurrence. In this study, we investigated whether the detection of CSC in axillary lymph node metastases (ALNM) might be a significant prognostic factor in patients with breast cancer.
Methods
From 1998 to 2006, 40 primary breast cancer patients with ALNM, the number of metastatic nodes varying in number from 1 to 3, underwent surgery at Okayama University; of these, 15 patients developed tumor recurrence. We retrospectively evaluated the common clinicopathological features and the expression of ER, HER2, ALDH1, and Ki67 in both the primary lesions and the ALNM, and analyzed the correlations between the expression of these biological markers and the disease-free survival (DFS).
Results
Expression of ALDH1 in the ALNM was significantly associated with the DFS (P = 0.037).
Conclusion
Evaluation of biomarker expression in ALNM could be useful for prognosis in breast cancer patients with 1–3 metastatic lymph nodes.
|
キーワード | Cancer stem cell
ALDH1
Axillary lymph node metastases
IHC
|
発行日 | 2012-03-10
|
出版物タイトル |
Breast Cancer
|
出版者 | Springer Japan
|
ISSN | 1880-4233
|
資料タイプ |
学術雑誌論文
|
オフィシャル URL | http://www.springerlink.com/content/76375p0214281kw5/
|
関連URL | http://ousar.lib.okayama-u.ac.jp/metadata/48889
|
言語 |
英語
|
著作権者 | © The Japanese Breast Cancer Society 2012
|
論文のバージョン | author
|
査読 |
有り
|
DOI | |
PubMed ID |